The Company's 2022 Second quarter consolidated
financial statements have been reported to the Board
Date of events
2022/08/11
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/11
2.Date of the audit committee approved:2022/08/11
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):2,024,399
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):853,489
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):217,009
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):496,138
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):439,861
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):526,397
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.61
11.Total assets end of the period (thousand NTD):10,638,078
12.Total liabilities end of the period
(thousand NTD):4,259,908
13.Equity attributable to owners of parent end of the
period (thousand NTD):4,995,614
14.Any other matters that need to be specified:none
Attachments
Original Link
Original Document
Permalink
Disclaimer
Synmosa Biopharma Corporation published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 07:40:08 UTC.
SYNMOSA BIOPHARMA CORPORATION is a Taiwan-based company principally engaged in the manufacture and sales of various kinds of pharmaceuticals and medical equipment. The Company's main products include respiratory drugs, cardiovascular and urinary drugs, gastrointestinal drugs, hormones, anti-tumor drugs, antibiotics and health products. The Company is also involved in the manufacture and sales of various kinds of cosmetics and animal medicines, as well as various kinds of chemical food additives and beverages. The Company distributes its products in domestic market and to overseas markets.